{
    "doi": "https://doi.org/10.1182/blood.V126.23.5018.5018",
    "article_title": "Follicular Lymphoma B Cells Generate Functional Regulatory T Cells Via ICOS/ICOSL Pathway and Are Inhibited By Intratumoral Tregs ",
    "article_date": "December 3, 2015",
    "session_type": "622. Non-Hodgkin Lymphoma: Biology, excluding Therapy",
    "abstract_text": "The prognosis of follicular lymphoma (FL) patients is suspected to be influenced by tumor infiltrating regulatory T cells (Tregs). The mechanism of Tregs enrichment in FL and their impact on malignant FL B cells remains to be elucidated. We analyzed 46 fresh lymph node biopsy samples including FL (n = 20), diffuse large B cell lymphoma (DLBCL; n = 10), classical Hodgkin lymphoma (cHL; n = 9) and reactive lymphadenitis (rL; n = 7). Using multicolor flow cytometry and cell sorting, we observed an accumulation of CD25 high CD127 low/ - Tregs in FL tissues. These Tregs comprised activated ICOS + Tregs which were able to suppress not only conventional T cells, but also FL B cells. These FL B cells were able to express ICOSL in vitro and to generate CD25 high Foxp3 high Tregs expressing ICOS. Tregs generation was associated with ICOS/ICOSL engagement and was abrogated by antagonist anti-ICOS and anti-ICOSL antibodies. Interaction between Tregs and FL B cells resulted in ICOSL downregulation on FL B cells. These data highlight the role of Tregs in FL pathogenesis and suggest that targeting the ICOS/ICOSL pathway may be a promising immunotherapy in FL Disclosures No relevant conflicts of interest to declare.",
    "topics": [
        "b-lymphocytes",
        "follicular lymphoma",
        "regulatory t-lymphocytes",
        "antigens, cd25",
        "diffuse large b-cell lymphoma",
        "antagonists",
        "antibodies",
        "cell separation",
        "chlorambucil",
        "flow cytometry"
    ],
    "author_names": [
        "Daniel Olive, MD, PhD",
        "Suong Khieu LE, PhD",
        "marie-Laure Thibult",
        "Francoise gondois-Rey",
        "Samuel Granjeaud, PhD",
        "Thierry Fest",
        "Azzaoui Imene",
        "Reda Bouabdallah, MD",
        "Florence Broussais",
        "Luc Xerri",
        "Dominique Leroux",
        "Christophe Caux",
        "Christine Caux"
    ],
    "author_dict_list": [
        {
            "author_name": "Daniel Olive, MD, PhD",
            "author_affiliations": [
                "CRCM [Immunity and Cancer], Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Universit\u00e9, UM 105; CNRS, UMR7258, Marseille, France "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Suong Khieu LE, PhD",
            "author_affiliations": [
                "crcm, marseille, France "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "marie-Laure Thibult",
            "author_affiliations": [
                "crcm, marseille, France "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francoise gondois-Rey",
            "author_affiliations": [
                "crcm, marseille, France "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Samuel Granjeaud, PhD",
            "author_affiliations": [
                "crcm, marseille, France "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Thierry Fest",
            "author_affiliations": [
                "INSERM U917, CHU Pontchaillou, Rennes, France "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Azzaoui Imene",
            "author_affiliations": [
                "INSERM U917, CHU de Rennes, Rennes, France "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Reda Bouabdallah, MD",
            "author_affiliations": [
                "Hematology Department, Lymphoma Program, Institut Paoli-Calmettes, Marseille, France "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Florence Broussais",
            "author_affiliations": [
                "Hematology Department, marseille, France "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luc Xerri",
            "author_affiliations": [
                "Institut Paoli-Calmettes, Marseille, France "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dominique Leroux",
            "author_affiliations": [
                "CHU Grenoble, grenoble, France "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christophe Caux",
            "author_affiliations": [
                "CRCL, Lyon, France"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christine Caux",
            "author_affiliations": [
                "CRCL, Lyon, France"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-02T04:22:44",
    "is_scraped": "1"
}